申请人:Merck Patent Gesellschaft mit beschraenkterHaftung
公开号:US06380430B1
公开(公告)日:2002-04-30
Novel compounds of the formula I
in which
X, R1, R2, R3, R4 and R5 have the meaning indicated in Patent Claim 1,
are inhibitors of the coagulation factor Xa and can be employed for the prophylaxis and/or therapy of thromboembolic disorders.
公式I中的X、R1、R2、R3、R4和R5的含义如专利权要求书1所示的新化合物是凝血因子Xa的抑制剂,可用于预防和/或治疗血栓栓塞性疾病。